Cns Pharmaceuticals Inc (NASDAQ: CNSP) is -99.82% lower on its value in year-to-date trading and has touched a low of $0.10 and a high of $116.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CNSP stock was last observed hovering at around $0.12 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.11, the stock is -5.03% and -10.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.34 million and changing -2.95% at the moment leaves the stock -97.99% off its SMA200. CNSP registered -99.89% loss for a year compared to 6-month loss of -98.96%. The firm has a 50-day simple moving average (SMA 50) of $0.12568 and a 200-day simple moving average (SMA200) of $5.58057.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.82% gain in the last 1 month and extending the period to 3 months gives it a -28.75%, and is -13.85% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.01% over the week and 13.37% over the month.
Cns Pharmaceuticals Inc (CNSP) has around 5 employees, a market worth around $6.25M and $0.00M in sales. Distance from 52-week low is 17.28% and -99.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-508.80%).
.
Cns Pharmaceuticals Inc (CNSP) Top Institutional Holders
12.0 institutions hold shares in Cns Pharmaceuticals Inc (CNSP), with institutional investors hold 0.80% of the company’s shares. The shares outstanding are 57.49M, and float is at 56.56M with Short Float at 1.21%. Institutions hold 0.79% of the Float.
Cns Pharmaceuticals Inc (CNSP) Insider Activity
The most recent transaction is an insider purchase by Gumulka Jerzy, the company’s Director. SEC filings show that Gumulka Jerzy bought 33,333 shares of the company’s common stock on Feb 01 ’24 at a price of $0.30 per share for a total of $10000.0. Following the purchase, the insider now owns 43006.0 shares.
Cns Pharmaceuticals Inc disclosed in a document filed with the SEC on Feb 01 ’24 that Evans Carl Anthony (Director) bought a total of 33,333 shares of the company’s common stock. The trade occurred on Feb 01 ’24 and was made at $0.30 per share for $10000.0. Following the transaction, the insider now directly holds 33458.0 shares of the CNSP stock.
Still, SEC filings show that on Feb 01 ’24, Downs Christopher (Chief Financial Officer) acquired 66,666 shares at an average price of $0.30 for $20000.0. The insider now directly holds 103,438 shares of Cns Pharmaceuticals Inc (CNSP).
